Treatment of subchondral cystic lesions of the medial femoral condyle of mature horses with growth factor enhanced chondrocyte grafts: a retrospective study of 49 cases.
Authors: Ortved K F, Nixon A J, Mohammed H O, Fortier L A
Journal: Equine veterinary journal
Summary
# Editorial Summary Subchondral cystic lesions of the medial femoral condyle represent a significant orthopaedic challenge in sport horses, and whilst arthroscopic debridement remains standard practice, outcomes have historically been variable. Ortved and colleagues evaluated 49 mature horses treated with a combination approach: arthroscopic debridement followed by bone void filling (cancellous bone or tricalcium phosphate granules) and overlaid with allogeneic chondrocytes suspended in fibrinogen-thrombin sealant enriched with insulin-like growth factor-I. Overall success—defined as return to intended use without lameness—was achieved in 36 horses (74%), with notably strong outcomes in older horses (80% success in horses >3 years old) and those with pre-existing osteoarthritis (80% success), neither of which negatively influenced prognosis as might be expected from debridement alone. The cyst size and age at presentation did not predict outcome, suggesting that growth factor-enhanced chondrocyte grafting may offer superior long-term results compared with conventional surgical approaches, particularly valuable for managing this condition in competition horses where functional recovery is paramount. These findings warrant consideration of biological augmentation strategies in your surgical protocol when treating femoral condyle cysts, especially in older individuals where conservative approaches have previously shown limited durability.
Read the full abstract on PubMed
Practical Takeaways
- •Chondrocyte grafting with IGF-I is a viable treatment option for subchondral cystic lesions in the femoral condyle, with nearly 3 in 4 horses returning to work without lameness
- •Older horses and those with existing osteoarthritis respond well to this treatment (80% success), making it a reasonable choice even in these populations rather than limiting treatment to younger horses
- •This biological approach may offer better long-term outcomes than traditional arthroscopic debridement alone, particularly for horses intended to return to athletic use
Key Findings
- •74% of horses (36/49) achieved successful outcome after chondrocyte and IGF-I grafting of subchondral cystic lesions
- •Success rate was 80% in horses older than 3 years and 80% in horses with pre-existing osteoarthritis, showing no negative impact from these factors
- •Preoperative cyst size and presence of osteoarthritis did not significantly influence treatment outcome
- •Chondrocyte implantation with IGF-I supplementation appears superior to debridement alone for long-term success